Margolis to Maintain a Part-time Presence at NIDDK Post-Retirement

Ron Margolis, PhD
Ron Margolis, PhD

After 26 years at the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) at the National Institutes of Health (NIH), Society member Ronald Margolis, PhD, will retire from his role as senior advisor for molecular endocrinology in the Division of Diabetes, Endocrinology and Metabolic Diseases and Co-lead, BD2K Data Discovery Index, effective September 25.

However, he will not be leaving entirely; he will return on September 28 as a part-time NIH employee in the Office of the Associate Director for Data Sciences continuing his work on biomedical big data. “With NIDDK I have had the privilege of working with the Society membership and staff to communicate the mission of NIDDK as it relates to that of the Endocrine Society,” he says. “This has entailed presentations at annual meetings, the NIH Lounge, lectures, and workshops – all focused on defining and creating synergies for members.”
Margolis says that the experience has been a “two-way street” since he has always learned from these interactions, with the added bonus of bringing back to NIDDK the real concerns of the membership over grants funding, NIH policies and procedures, and the general state of the research enterprise. “The Endocrine Society is also my professional home,” he says, adding “I’ve been an active member since 1981 and attended meetings as a student and fellow prior to becoming a member.”

As a long-time member, Margolis has always been concerned about the health and vitality of the Society. “Over the years I have contributed to strategic planning and have worked with all presidents since joining the NIH in 1989,” he says. “All-in-all it has been a pleasure to serve two masters — the NIH and the Endocrine Society. I look forward to continuing my membership as I move ahead with this coming transition.”

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

Find more in